November 17, 2011 – The Department of Defense has awarded Entegrion, of which Dr. Preston Rich is Vice President and Chief Medical Officer, $43.7 million to develop a plasma-derived drug that may someday be a substitute for fresh frozen plasma.
Preston “Chip” Rich, MD, MBA, FACS, is Associate Professor of Surgery and Chief of the Division of Trauma/Critical Care.